CA
NZ
UK
AU
IND
US
HUTCHMED is a Hong Kong-headquartered, commercial-stage biopharmaceutical company founded in 2000 that discovers, develops and commercializes targeted therapies and immunotherapies for cancer and immunological diseases. Its marketed and pipeline portfolio includes fruquintinib, surufatinib and savolitinib, plus candidates such as sovleplenib, tazemetostat and fanregatinib. It …
IDEXX, based in Westbrook, Maine, develops and distributes diagnostics, software and water testing products for pet healthcare, livestock, poultry and dairy customers in more than 175 countries. Its Companion Animal Group sells in-clinic analyzers such as Catalyst, ProCyte Dx and SediVue Dx, along with …
Immunome, based in Bothell, Washington, is a clinical-stage targeted oncology company developing first-in-class and best-in-class cancer therapies, with a focus on antibody-drug conjugates. Its lead asset is varegacestat, aGammasecretase inhibitor for desmoid tumors. In December 2025 the company announced positive topline results from the …
Inovio, based in Plymouth Meeting, Pennsylvania, is a biotechnology company developing DNA medicines for HPV-related diseases, cancer and infectious diseases. Its platform pairs SynCon-engineered DNA plasmids with CELLECTRA smart devices, and VOCERYQ is the first product built on it to win FDA approval.
Johnson & Johnson is a New Brunswick, New Jersey-based healthcare company founded in 1886. Following the 2023 separation of its consumer business, it operates two segments. Innovative Medicine, about 64% of 2025 revenue, focuses on oncology, immunology, neuroscience, cardiovascular and metabolism, and pulmonary hypertension. …
Krystal Biotech, based in Pittsburgh, is a fully integrated, commercial-stage genetic medicines company. It uses a proprietary HSV-1 vector platform and in-houseManufacturingto develop redosable gene therapies for rare diseases with high unmet need. Its first product, Vyjuvek, is the first redosable gene therapy approved …
Royal Philips is an Amsterdam-headquartered health technology company founded in 1891 that has refocused from its lighting and consumer electronics roots on healthcare and personal well-being. It operates through Diagnosis & Treatment, which covers imaging, ultrasound and image-guided therapy, Connected Care, which covers patient …
Precigen is a Germantown, Maryland-based commercial-stage biopharmaceutical company that develops gene and cell therapies for immuno-oncology, autoimmune disorders and infectious diseases. Papzimeos, known generically as zopapogene imadenovec-drba, is an FDA-approved immunotherapy for adults with recurrent respiratory papillomatosis, built on the AdenoVerse platform, which the …
Propanc is a pre-revenue biotechnology company based in Australia and founded in 2007. It develops proenzyme-based therapies to prevent cancer recurrence and metastasis in pancreatic, ovarian and colorectal cancers by targeting cancer stem cells. Its lead candidate, PRP, now called PPC-001, is an intravenous …
QuidelOrtho, based in San Diego, is a leading global in vitro diagnostics provider formed by the 2022Mergerof Quidel and Ortho Clinical Diagnostics. It operates fourBusinessunits: Labs, which covers clinical chemistry and immunoassay including the VITROS systems, Transfusion Medicine, Point of Care, which includes the …
Please wait processing your request...